This company has been marked as potentially delisted and may not be actively trading. Oasmia Pharmaceutical AB (publ) (OASM) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock OASM vs. CPHI, NRBO, ADXS, MTNB, CANF, NBY, SPRB, AFMD, GRAY, and PTNShould you be buying Oasmia Pharmaceutical AB (publ) stock or one of its competitors? The main competitors of Oasmia Pharmaceutical AB (publ) include China Pharma (CPHI), NeuroBo Pharmaceuticals (NRBO), Ayala Pharmaceuticals (ADXS), Matinas Biopharma (MTNB), Can-Fite BioPharma (CANF), NovaBay Pharmaceuticals (NBY), Spruce Biosciences (SPRB), Affimed (AFMD), Graybug Vision (GRAY), and Palatin Technologies (PTN). Oasmia Pharmaceutical AB (publ) vs. Its Competitors China Pharma NeuroBo Pharmaceuticals Ayala Pharmaceuticals Matinas Biopharma Can-Fite BioPharma NovaBay Pharmaceuticals Spruce Biosciences Affimed Graybug Vision Palatin Technologies China Pharma (NYSE:CPHI) and Oasmia Pharmaceutical AB (publ) (NASDAQ:OASM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership. Which has more risk and volatility, CPHI or OASM? China Pharma has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Comparatively, Oasmia Pharmaceutical AB (publ) has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Does the media refer more to CPHI or OASM? In the previous week, China Pharma had 1 more articles in the media than Oasmia Pharmaceutical AB (publ). MarketBeat recorded 1 mentions for China Pharma and 0 mentions for Oasmia Pharmaceutical AB (publ). China Pharma's average media sentiment score of 0.34 beat Oasmia Pharmaceutical AB (publ)'s score of 0.00 indicating that China Pharma is being referred to more favorably in the media. Company Overall Sentiment China Pharma Neutral Oasmia Pharmaceutical AB (publ) Neutral Is CPHI or OASM more profitable? China Pharma has a net margin of -85.56% compared to Oasmia Pharmaceutical AB (publ)'s net margin of -8,633.64%. Oasmia Pharmaceutical AB (publ)'s return on equity of -43.94% beat China Pharma's return on equity.Company Net Margins Return on Equity Return on Assets China Pharma-85.56% -63.93% -31.42% Oasmia Pharmaceutical AB (publ) -8,633.64%-43.94%-28.92% Do institutionals and insiders have more ownership in CPHI or OASM? 0.1% of Oasmia Pharmaceutical AB (publ) shares are held by institutional investors. 17.3% of China Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, CPHI or OASM? China Pharma has higher revenue and earnings than Oasmia Pharmaceutical AB (publ). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina Pharma$4.30M1.40-$3.08MN/AN/AOasmia Pharmaceutical AB (publ)$220K6.82-$18.95MN/AN/A SummaryChina Pharma beats Oasmia Pharmaceutical AB (publ) on 6 of the 11 factors compared between the two stocks. Get Oasmia Pharmaceutical AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for OASM and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OASM vs. The Competition Export to ExcelMetricOasmia Pharmaceutical AB (publ)Pharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.50M$790.73M$5.54B$9.05BDividend YieldN/A4.84%5.24%4.02%P/E RatioN/A1.3527.4320.23Price / Sales6.82226.97422.11118.64Price / CashN/A23.4436.8958.07Price / Book0.036.298.045.67Net Income-$18.95M-$27.73M$3.18B$249.13M Oasmia Pharmaceutical AB (publ) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OASMOasmia Pharmaceutical AB (publ)N/A$0.02flatN/AN/A$1.50M$220K0.0057CPHIChina Pharma0.3616 of 5 stars$1.75-3.6%N/A-93.0%$5.69M$4.30M0.00250High Trading VolumeNRBONeuroBo PharmaceuticalsN/A$0.65+1.1%N/A-85.5%$5.60MN/A0.0010News CoverageGap DownADXSAyala PharmaceuticalsN/A$0.12+261.3%N/A-41.6%$5.13M$3.24M-0.0220Gap UpMTNBMatinas BiopharmaN/A$0.94+4.1%N/AN/A$4.78MN/A-0.1930CANFCan-Fite BioPharma3.3171 of 5 stars$1.03-1.0%$14.00+1,259.2%-57.9%$3.65M$674K-0.588Gap UpNBYNovaBay Pharmaceuticals2.0566 of 5 stars$0.63+2.6%$0.85+36.0%-71.0%$3.64M$9.78M-0.0130SPRBSpruce Biosciences2.1945 of 5 stars$0.07+2.5%$1.75+2,300.5%-87.2%$3.08M$4.91M-0.0820News CoverageAFMDAffimed2.9753 of 5 stars$0.18-34.9%$3.62+1,895.9%-96.4%$2.92M$877K0.00200Gap DownHigh Trading VolumeGRAYGraybug VisionN/A$1.56-2.5%N/A-62.2%$2.45MN/A-0.9027Gap UpHigh Trading VolumePTNPalatin TechnologiesN/A$0.09-44.6%N/AN/A$2.45M$350K-0.0630Gap DownHigh Trading Volume Related Companies and Tools Related Companies CPHI Competitors NRBO Competitors ADXS Competitors MTNB Competitors CANF Competitors NBY Competitors SPRB Competitors AFMD Competitors GRAY Competitors PTN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OASM) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oasmia Pharmaceutical AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Oasmia Pharmaceutical AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OASM Stock Alerts